Top Story

Pemetrexed benefited lung cancer patients with ALK mutations

January 29, 2015

Patients with lung adenocarcinoma who have anaplastic lymphoma kinase gene mutations derived greater benefit from pemetrexed-based therapy than those without the mutations, according to results of a retrospective analysis performed in Korea.

Benefits observed in this patient population included a higher response rate and longer PFS.

Srdan Verstovsek In the Journals

Ruxolitinib superior to standard therapy for polycythemia vera

January 28, 2015
Patients with polycythemia vera who were resistant to or intolerant of hydroxyurea therapy demonstrated better controlled hematocrit levels, reduced spleen volume and…
Gregory Armstrong, MD In the Journals

Variation in risk for late mortality among pediatric cancer survivors can persist up to 20 years post-diagnosis

January 28, 2015
Although all survivors of pediatric cancer face increased risk for death, the risk is reduced as survivors age through childhood and young adulthood, according to study…
In the Journals

Confocal laser endomicroscopy improved detection of biliary cancer

January 28, 2015
When combined with tissue sampling, using probe-based confocal laser endomicroscopy during endoscopic retrograde cholangio-pancreatography diagnosed cholangiocarcinoma…

Clinical trial of procedure to relieve spinal cancer pain launched

January 28, 2015
Loyola University Medical Center has launched the first clinical trial in the United States to test a new combination treatment that delivers radiation directly to the…
More News Headlines »
Hot melanoma

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates - Monograph

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
Meeting News Coverage Video
Genome editing demonstrated wide application for blood disorders

Genome editing demonstrated wide application for blood disorders

January 4, 2015
SAN FRANCISCO — Ralph Green, MD, PhD, FRCPath, medical director of the UC Davis Health System Medical…
More »
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
morganatic-roan morganatic-roan